Jazz Pharmaceuticals (JAZZN) Q1 2026 Earnings Report
MX:JAZZN Q1 2026 EPS Results
- Actual EPS
- MXN 117.81
- Consensus EPS
- MXN 86.24
- Beat/Miss
- Beat by +MXN 31.57
- One Year Ago EPS
- MXN 31.22
MX:JAZZN Q1 2026 Revenue Results
- Actual Revenue
- MXN 19.86B
- Expected Revenue
- MXN 18.19B
- Beat/Miss
- Beat by +MXN 1.68B
- YoY Revenue Growth
- +19.05%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/05/2026
- Time
- After Close
- Conference Call
- Tuesday, May 5, 2026
MX:JAZZN Upcoming Earnings
Jazz Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
MX:JAZZN Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:JAZZN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 121.18- | 123.39 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -75.18-72.10 | 151.07 | -147.72% (-223.17) | |
| Aug 03, 2026 | 2026 (Q2) | 114.75106.11 | -153.3 | 169.21% (+259.41) | |
| May 05, 2026 | 2026 (Q1) | 86.24117.81 | 31.22 | 277.38% (+86.59) | |
| Feb 24, 2026 | 2025 (Q4) | 121.12123.39 | 122.64 | 0.61% (+0.74) | |
| Nov 05, 2025 | 2025 (Q3) | 110.49151.07 | 122.83 | 23.00% (+28.25) | |
| Aug 05, 2025 | 2025 (Q2) | -141.34-153.30 | 98.49 | -255.66% (-251.79) | |
| May 06, 2025 | 2025 (Q1) | 86.5631.22 | 49.8 | -37.31% (-18.58) | |
| Feb 25, 2025 | 2024 (Q4) | 108.93122.64 | 93.28 | 31.47% (+29.36) | |
| Nov 06, 2024 | 2024 (Q3) | 102.17122.83 | 89.94 | 36.57% (+32.89) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
